SEC 13F · Q3 2026

Health Care Stocks Held by Hedge Funds

All health care-sector stocks held by tracked institutional funds per the latest SEC 13F filings, sorted by number of fund holders.

ALLO Allogene Therapeutics
0.67 -4.17%
Health Care 1M -49.9%
143Funds Holding
$318.85MInstitutional value
-71vs last quarter
Marshall Wace Renaissance Technologies Millennium Management D. E. Shaw & Co +139 View holders →
LEGN Legend Biotech
16.10 -0.92%
Health Care 1M -13.6%
143Funds Holding
$1.01BInstitutional value
-82vs last quarter
Renaissance Technologies Marshall Wace +141 View holders →
CDRE Cadre Holdings
30.56 -4.14%
Health Care 1M +11.1%
142Funds Holding
$608.66MInstitutional value
-21vs last quarter
AQR Capital Management Renaissance Technologies Millennium Management Arrowstreet Capital +138 View holders →
ESTA Establishment Labs Holdings
69.61 -1.68%
Health Care 1M +11.8%
141Funds Holding
$1.04BInstitutional value
-68vs last quarter
D. E. Shaw & Co Millennium Management Renaissance Technologies AQR Capital Management +137 View holders →
ALT Altimmune
1.41 +1.44%
Health Care 1M -36.8%
140Funds Holding
$248.70MInstitutional value
-82vs last quarter
Viking Global Investors Marshall Wace Millennium Management D. E. Shaw & Co +136 View holders →
ALMS Alumis
4.33 -1.48%
Health Care 1M -36.4%
139Funds Holding
$297.46MInstitutional value
-73vs last quarter
Millennium Management Marshall Wace AQR Capital Management D. E. Shaw & Co +135 View holders →
SGRY Surgery Partners
26.69 -1.00%
Health Care 1M +73.3%
139Funds Holding
$663.78MInstitutional value
-60vs last quarter
Arrowstreet Capital AQR Capital Management Marshall Wace +136 View holders →
CERS Cerus
1.90 -2.06%
Health Care 1M -20.5%
138Funds Holding
$286.24MInstitutional value
-56vs last quarter
ARK Invest D. E. Shaw & Co AQR Capital Management Renaissance Technologies +134 View holders →
EBS Emergent Biosolutions
5.15 -6.36%
Health Care 1M -16.9%
138Funds Holding
$219.59MInstitutional value
-67vs last quarter
Millennium Management D. E. Shaw & Co AQR Capital Management Renaissance Technologies +134 View holders →
ELVN Enliven Therapeutics
46.41 +3.39%
Health Care 1M +11.0%
138Funds Holding
$1.88BInstitutional value
-84vs last quarter
Marshall Wace Millennium Management Renaissance Technologies D. E. Shaw & Co +134 View holders →
SPRY Ars Pharmaceuticals
3.36 -8.94%
Health Care 1M -19.6%
138Funds Holding
$189.56MInstitutional value
-78vs last quarter
Millennium Management Third Point Marshall Wace Renaissance Technologies +134 View holders →
TSHA Taysha Gene Therapies
3.77 -5.51%
Health Care 1M -8.5%
138Funds Holding
$698.95MInstitutional value
-78vs last quarter
D. E. Shaw & Co Farallon Capital Management Millennium Management AQR Capital Management +134 View holders →
ANNX Annexon
3.41 -3.12%
Health Care 1M -11.7%
137Funds Holding
$445.04MInstitutional value
-87vs last quarter
Arrowstreet Capital Marshall Wace AQR Capital Management Millennium Management +133 View holders →
AGL Agilon Health
89.50 -1.14%
Health Care 1M -1.6%
136Funds Holding
$1.07BInstitutional value
-49vs last quarter
AQR Capital Management Marshall Wace Renaissance Technologies D. E. Shaw & Co +132 View holders →
ZVRA Zevra Therapeutics
9.07 -2.26%
Health Care 1M -12.5%
136Funds Holding
$411.89MInstitutional value
-34vs last quarter
D. E. Shaw & Co Arrowstreet Capital Millennium Management AQR Capital Management +132 View holders →
DNA Ginkgo Bioworks Holdings
8.20 -2.84%
Health Care 1M -18.1%
135Funds Holding
$375.54MInstitutional value
-59vs last quarter
Viking Global Investors D. E. Shaw & Co Renaissance Technologies Millennium Management +131 View holders →
PRTA Prothena
8.40 +0.60%
Health Care 1M +4.6%
135Funds Holding
$247.29MInstitutional value
-62vs last quarter
D. E. Shaw & Co AQR Capital Management Renaissance Technologies Marshall Wace +131 View holders →
ACB Aurora Cannabis
4.26 -3.18%
Health Care 1M +7.6%
134Funds Holding
$15.41MInstitutional value
-23vs last quarter
Renaissance Technologies D. E. Shaw & Co +132 View holders →
PSNL Personalis
14.72 -1.74%
Health Care 1M -7.4%
134Funds Holding
$1.03BInstitutional value
-32vs last quarter
ARK Invest Millennium Management Marshall Wace Soros Fund Management +130 View holders →
MBX Mbx Biosciences
53.41 -0.02%
Health Care 1M -1.0%
133Funds Holding
$1.67BInstitutional value
-48vs last quarter
D. E. Shaw & Co Marshall Wace AQR Capital Management +130 View holders →
PRME Prime Medicine
3.84 +0.52%
Health Care 1M +0.8%
133Funds Holding
$235.11MInstitutional value
-64vs last quarter
ARK Invest Farallon Capital Management Millennium Management Marshall Wace +129 View holders →
SIBN Si-Bone
23.75 +0.89%
Health Care 1M +14.1%
133Funds Holding
$500.44MInstitutional value
-44vs last quarter
Marshall Wace D. E. Shaw & Co AQR Capital Management Millennium Management +129 View holders →
CTMX Cytomx Therapeutics
2.05 +9.04%
Health Care 1M -14.6%
132Funds Holding
$317.03MInstitutional value
-52vs last quarter
Marshall Wace Millennium Management AQR Capital Management +129 View holders →
MGTX Meiragtx Holdings
8.14 -2.16%
Health Care 1M -17.4%
132Funds Holding
$461.09MInstitutional value
-32vs last quarter
Millennium Management Arrowstreet Capital D. E. Shaw & Co Renaissance Technologies +128 View holders →
AVXL Anavex Life Sciences
0.67 -7.21%
Health Care 1M -50.9%
131Funds Holding
$61.05MInstitutional value
-59vs last quarter
Marshall Wace AQR Capital Management D. E. Shaw & Co Renaissance Technologies +127 View holders →
OMDA Omada Health
12.50 -5.09%
Health Care 1M -36.4%
131Funds Holding
$888.91MInstitutional value
-31vs last quarter
D. E. Shaw & Co Millennium Management Marshall Wace Arrowstreet Capital +127 View holders →
VNDA Vanda Pharmaceuticals
3.67 -2.13%
Health Care 1M -8.5%
131Funds Holding
$561.56MInstitutional value
-49vs last quarter
Millennium Management Renaissance Technologies AQR Capital Management Marshall Wace +127 View holders →
BVS Bioventus
9.95 -6.31%
Health Care 1M -30.1%
130Funds Holding
$596.68MInstitutional value
-36vs last quarter
Renaissance Technologies AQR Capital Management Arrowstreet Capital Marshall Wace +126 View holders →
MYGN Myriad Genetics
5.54 +0.18%
Health Care 1M -0.5%
130Funds Holding
$284.13MInstitutional value
-75vs last quarter
Millennium Management D. E. Shaw & Co Marshall Wace AQR Capital Management +126 View holders →
RIGL Rigel Pharmaceuticals
41.19 -3.15%
Health Care 1M -15.7%
130Funds Holding
$547.98MInstitutional value
-34vs last quarter
D. E. Shaw & Co Marshall Wace AQR Capital Management Renaissance Technologies +126 View holders →
ANGO Angiodynamics
10.76 -4.95%
Health Care 1M -9.5%
129Funds Holding
$390.42MInstitutional value
-43vs last quarter
Arrowstreet Capital AQR Capital Management Renaissance Technologies Marshall Wace +125 View holders →
BLLN Billiontoone Inc Cl A
90.20 -1.46%
Health Care 1M -13.8%
129Funds Holding
$1.42BInstitutional value
-38vs last quarter
Millennium Management Marshall Wace Renaissance Technologies D. E. Shaw & Co +125 View holders →
GLUE Monte Rosa Therapeutics
8.91 -1.76%
Health Care 1M -20.6%
129Funds Holding
$508.27MInstitutional value
-75vs last quarter
AQR Capital Management Marshall Wace Millennium Management +126 View holders →
GRFS Grifols S A
8.20 -3.19%
Health Care 1M +9.3%
129Funds Holding
$586.52MInstitutional value
-42vs last quarter
Millennium Management Arrowstreet Capital AQR Capital Management +126 View holders →
PBYI Puma Biotechnology
7.12 -1.39%
Health Care 1M -34.7%
129Funds Holding
$280.83MInstitutional value
-38vs last quarter
Renaissance Technologies Arrowstreet Capital AQR Capital Management D. E. Shaw & Co +125 View holders →
SRTA Strata Critical Medical
4.83 -2.62%
Health Care 1M +2.1%
129Funds Holding
$241.32MInstitutional value
-21vs last quarter
Third Point AQR Capital Management Renaissance Technologies Millennium Management +125 View holders →
CGEM Cullinan Therapeutics
9.07 +0.67%
Health Care 1M -39.1%
128Funds Holding
$475.19MInstitutional value
-61vs last quarter
AQR Capital Management Renaissance Technologies Millennium Management Arrowstreet Capital +124 View holders →
ORIC Oric Pharmaceuticals
7.70 +0.65%
Health Care 1M -44.4%
128Funds Holding
$733.54MInstitutional value
-59vs last quarter
Viking Global Investors D. E. Shaw & Co Millennium Management AQR Capital Management +124 View holders →
NAMS Newamsterdam Pharmaceuticals
19.51 -1.17%
Health Care 1M -9.2%
127Funds Holding
$1.54BInstitutional value
-83vs last quarter
Viking Global Investors Maverick Capital Millennium Management AQR Capital Management +123 View holders →
OLMA Olema Pharmaceuticals
7.15 +1.27%
Health Care 1M +1.4%
127Funds Holding
$448.94MInstitutional value
-61vs last quarter
D. E. Shaw & Co AQR Capital Management Millennium Management +124 View holders →
CRVS Corvus Pharmaceuticals
10.01 -1.77%
Health Care 1M -0.4%
125Funds Holding
$426.72MInstitutional value
-54vs last quarter
Millennium Management D. E. Shaw & Co Marshall Wace +122 View holders →
HRTX Heron Therapeutics
0.26 -3.26%
Health Care 1M -22.3%
125Funds Holding
$16.32MInstitutional value
-44vs last quarter
AQR Capital Management Renaissance Technologies Millennium Management Marshall Wace +121 View holders →
STOK Stoke Therapeutics
26.93 +0.90%
Health Care 1M +4.9%
125Funds Holding
$1.03BInstitutional value
-79vs last quarter
Millennium Management Marshall Wace D. E. Shaw & Co AQR Capital Management +121 View holders →
CMPX Compass Therapeutics
0.68 +11.05%
Health Care 1M -16.7%
124Funds Holding
$73.85MInstitutional value
-100vs last quarter
Millennium Management AQR Capital Management D. E. Shaw & Co Marshall Wace +120 View holders →
OABI Omniab
5.03 -0.98%
Health Care 1M +2.3%
124Funds Holding
$192.04MInstitutional value
-15vs last quarter
Arrowstreet Capital D. E. Shaw & Co Renaissance Technologies Millennium Management +120 View holders →
RGNX Regenxbio
7.18 -1.10%
Health Care 1M +0.1%
124Funds Holding
$287.11MInstitutional value
-52vs last quarter
AQR Capital Management D. E. Shaw & Co Marshall Wace Millennium Management +120 View holders →
TRAX First Tracks Biotherapeutics
44.46 -0.09%
Health Care 1M +4.0%
124Funds Holding
$596.74MInstitutional value
-31vs last quarter
Millennium Management Marshall Wace AQR Capital Management Renaissance Technologies +120 View holders →
EOLS Evolus
7.00 -0.99%
Health Care 1M -5.4%
123Funds Holding
$241.13MInstitutional value
-45vs last quarter
Millennium Management Renaissance Technologies D. E. Shaw & Co AQR Capital Management +119 View holders →
TCMD Tactile Sys Technology
25.99 -1.63%
Health Care 1M +11.6%
123Funds Holding
$336.14MInstitutional value
-65vs last quarter
Arrowstreet Capital Renaissance Technologies D. E. Shaw & Co AQR Capital Management +119 View holders →
AKBA Akebia Therapeutics
0.42 +3.28%
Health Care 1M -27.8%
122Funds Holding
$70.32MInstitutional value
-55vs last quarter
AQR Capital Management Renaissance Technologies Millennium Management D. E. Shaw & Co +118 View holders →

1036 stocks in Health Care · prices as of 2026-11-19